中医药治疗肺癌恶性胸腔积液现状研究

A Study on the Status Quo of Traditional Chinese Medicine Therapy on Malignant Pleural Effusion of Lung Cancer

恶性胸腔积液是肺癌晚期常见的并发症。肺癌晚期患者往往不能耐受放化疗治疗,而中医药在改善症状、减少积液、提高生活质量、延长生存期等方面发挥了较大优势。本文对近年来中医药治疗肺癌恶性胸腔积液的方法进行分析,从辨证论治、口服汤药,内病外治、中药贴敷,中西合用、腔内注射等三个方面作了全面综述。

Malignant pleural effusion of lung cancer is a common complication in late lung cancer, but the patients of late lung cancer cannot endure radiotherapy and chemotherapy. Traditional Chinese medicine(TCM) has many advantages on improving symptoms, decreasing pleural effusion, enhancing life quality, and prolonging lifetime. This article analyzed the status quo of TCM therapy on malignant pleural effusion of lung cancer during the recent years. It concluded three therapeutic methods: treatment based on syndrome differentiation and taking decoction orally, treating an internal illness by external treatment and application of point application therapy, combination of Chinese and Western medicine and cavity injection.